Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 29,700 shares, a growth of 13.4% from the June 15th total of 26,200 shares. Currently, 0.3% of the shares of the company are […]
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) traded down 10.9% on Monday . The company traded as low as $1.07 and last traded at $1.10. 43,240 shares changed hands during mid-day trading, an increase of 235% from the average session volume of 12,903 shares. The stock had previously closed at $1.24. Armata Pharmaceuticals Stock […]
Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report)’s share price was down 10.9% during trading on Monday . The company traded as low as $1.07 and last traded at $1.10. Approximately 43,240 shares changed hands during mid-day trading, an increase of 235% from the average daily volume of 12,903 shares. The stock had previously closed […]
/PRNewswire/ The "Bacterial Therapeutics Beyond Antibiotics" report has been added to ResearchAndMarkets.com s offering. As bacteria grow resistant to.